Cargando…
Contents of Volume 138
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130391/ http://dx.doi.org/10.1016/S0021-9975(08)00044-3 |
| _version_ | 1783517000549531648 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7130391 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2008 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71303912020-04-08 Contents of Volume 138 J Comp Pathol Article Published by Elsevier Ltd. 2008-05 2008-04-11 /pmc/articles/PMC7130391/ http://dx.doi.org/10.1016/S0021-9975(08)00044-3 Text en © 2008 Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Contents of Volume 138 |
| title | Contents of Volume 138 |
| title_full | Contents of Volume 138 |
| title_fullStr | Contents of Volume 138 |
| title_full_unstemmed | Contents of Volume 138 |
| title_short | Contents of Volume 138 |
| title_sort | contents of volume 138 |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130391/ http://dx.doi.org/10.1016/S0021-9975(08)00044-3 |